Cepheid (CPHD) Higher After Expanding Development of 45-Minute Flu A Panel Test
Tweet Send to a Friend
Shares of Cepheid (Nasdaq: CPHD) are 5.6% higher today after the company announced it would accelerated development of a Flu ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
